Sharon Saban - 14 Oct 2026 Form 4 Insider Report for Nano-X Imaging Ltd. (NNOX)

Reporting relationship: General Manager AI Division
Issuer ticker: NNOX
Reported as of: 14 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Oct 2026, 16:05:35 UTC
Prior SEC filing: 07 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Marina Gofman Feler, attorney-in-fact

Key filing fact

Sharon Saban filed Form 4 for Nano-X Imaging Ltd. (NNOX) on 14 Oct 2026.

Key facts

This page summarizes Sharon Saban's Form 4 filing for Nano-X Imaging Ltd. (NNOX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Oct 2026, 16:05.

Change

Previous filing in this sequence was filed on 07 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002124822 Primary reporting owner

saban sharon

Relationship: General Manager AI Division
Address: C/O NANO-X IMAGING LTD., OFER TECH PARK, 94 SHLOMO SHMELTZER ROAD, PETACH TIKVA, ISRAEL
Signature: /s/ Marina Gofman Feler, attorney-in-fact
Signature date: 14 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NNOX transaction

Ordinary Shares

Award

Transaction value
Shares: +28,283
Change %
Price: $0.000000^*
Shares after: 28,283
Date: 14 Oct 2026
Ownership: Direct
Footnotes: F1, F2

NNOX holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 26,316
Date: 14 Oct 2026
Ownership: Direct
Footnotes: F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NNOX holding Derivative

Stock Option (right to buy ordinary shares)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 15,000
Date: 14 Oct 2026
Ownership: Direct
Underlying class: Ordinary shares
Underlying amount: 15,000
Exercise price: $17.63
Footnotes: F3, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The transaction reported in this row consists of the grant by the Issuer's board of directors to the Reporting Person of 28,283 ordinary shares represented by 28,283 restricted share units ("RSUs"), pursuant to the Issuer's 2019 Equity Incentive Plan.

Footnote F2

The 28,283 RSUs reported in this row vest and settle for underlying ordinary shares in four equal semi-annual installments of 25% each following the vesting commencement date of August 13, 2026-- on February 13, 2027, August 13, 2027, February 13, 2028 and August 13, 2028-- subject, in each case, to the Reporting Person's continuous employment by the Issuer as of the applicable vesting date, such that by the two-year anniversary of the vesting commencement date (August 13, 2028), all underlying shares will be issued to the Reporting Person.

Footnote F3

There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

Footnote F4

The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer on February 5, 2026, of which 50% vest and settle for underlying ordinary shares on the 12-month anniversary of the grant date (February 5, 2027) and the remaining 50% vest and settle on the 24-month anniversary of the grant date (February 5, 2028).

Footnote F5

The options reported in this row were granted to the Reporting Person by the Issuer on September 15, 2022 and are fully vested and exercisable as of the date of this report.

SEC remarks

Exhibit 24.1 - Power of Attorney